Related Experiment Video
Updated: Aug 7, 2026

Evaluation of Drug Sorption to PVC- and Non-PVC-based Tubes in Administration Sets Using a Pump
Published on: March 11, 2017
Variability of phenytoin, carbamazepine and valproate concentrations in a clinic population
1Comprehensive Epilepsy Program of Minnesota, Minneapolis 55414.
Abstract:
The Comprehensive Epilepsy Program of Minnesota database was searched for patients who had no dose change of carbamazepine (CBZ), phenytoin (PHT) or valproate (VPA) for 3 consecutive visits. Data from 860 patients were available. The coefficient of variation (CV) was calculated from 3 or more visits without dose change. For CBZ, 290 CV values from 206 individuals were available; the mode CV was 23.3%. For PHT 293 CVs were collected from 192 individuals; the mode CV was 25.2%. For VPA 244 CVs was 181 persons; the mode CV was 27.1%. If one uses the standard of a CV of less than 20% representing compliance with PHT, and a CV of less than 25% for CBZ and VPA, it appears that even in a specialty clinic, compliance with medication is a significant problem.
Related Concept Videos
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
A study on guinea pigs examined the...
Dosage Regimen: Individualization
Pharmacokinetics in Pediatric Patients: Drug Distribution
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Pharmacogenetics of Drug Metabolism: Overview

